Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
13.05
+0.11 (0.85%)
At close: Sep 5, 2025, 4:00 PM
12.68
-0.37 (-2.84%)
After-hours: Sep 5, 2025, 6:49 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $1.82 billion as of September 5, 2025. Its market cap has increased by 68.00% in one year.
Market Cap
1.82B
Enterprise Value
1.65B
1-Year Change
68.00%
Ranking
Category
Stock Price
$13.05
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $1.82B, an increase of 1,367.81%. That is a compound annual growth rate of 68.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 1.82B | 111.71% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |